ODDB.org: Open Drug Database

Gebro Pharma AG - Metoject 17.5 mg, Injektionslösung

Swissmedic Registration	57272	Sequence	13
Product name	Metoject 17.5 mg	Description	Injektionslösung
ATC-Classification	L04AX03	ATC-Description	Methotrexate
Introduction of Sequence	17.11.2011

Composition

methotrexatum 17.5 mg ut methotrexatum natricum, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 0.35 ml corresp. natrium 2.56 mg.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Methotrexate	17.5mg / 0.35ml

BAG: Active Agent	Dose
Methotrexate	17.5 mg

Inactive agents
Acidum Hydrochloridum
Sodium Chloride
Sodium Hydroxide

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
016				A		Yes
090	syringe(s)	19.36	37.40	A	SL	No
091	4 syringe(s)			A		Yes
092	6 syringe(s)			A		Yes
093	12 syringe(s)			A		Yes
094	24 syringe(s)			A		Yes

2025	©ywesee GmbH